PharmacyCodes



Moclobemida [Inn-Spanish] en es it fr

Moclobemida [Inn-Spanish] Brand names, Moclobemida [Inn-Spanish] Analogs

Moclobemida [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Moclobemida [Inn-Spanish] Chemical_Formula

C13H17ClN2O2

Moclobemida [Inn-Spanish] RX_link

No information avaliable

Moclobemida [Inn-Spanish] fda sheet

Moclobemida [Inn-Spanish] msds (material safety sheet)

Moclobemida [Inn-Spanish] Synthesis Reference

No information avaliable

Moclobemida [Inn-Spanish] Molecular Weight

268.739 g/mol

Moclobemida [Inn-Spanish] Melting Point

No information avaliable

Moclobemida [Inn-Spanish] H2O Solubility

No information avaliable

Moclobemida [Inn-Spanish] State

Solid

Moclobemida [Inn-Spanish] LogP

1.298

Moclobemida [Inn-Spanish] Dosage Forms

Tablet

Moclobemida [Inn-Spanish] Indication

For the treatment of depression.

Moclobemida [Inn-Spanish] Pharmacology

Moclobemide belongs to a class of MAOI antidepressants known as reversible inhibitors of monoamine oxidase type-A (RIMAs). The primary role of monoamine oxidase MAO lies in the metabolism of and regulation of the levels of monoamines (serotonin, norepinephrine, and dopamine). Within neurons, MAO appears to regulate the levels of monoamines released upon synaptic firing. Since depression is associated with low levels of monoamines, the inhibition of MAO serves to ease depressive symptoms. RIMAs demonstrate transient inhibition of the substrate binding site of MAO-A as well as competitive displacement from this site by bioamines. The RIMAs are distinguished from the older monoamine oxidase inhibitors (MAOIs) by their selectivity and reversibility.

Moclobemida [Inn-Spanish] Absorption

No information avaliable

Moclobemida [Inn-Spanish] side effects and Toxicity

No information avaliable

Moclobemida [Inn-Spanish] Patient Information

No information avaliable

Moclobemida [Inn-Spanish] Organisms Affected

Humans and other mammals